… reduced considerably if patients are monitored by molecular … , or competitive reverse
transcriptase polymerase chain reaction (… trial of interferon-alpha n 1 for chronic myeloid …

… Competitive or real-time quantitative reverse transcriptase … in CML patients in complete
remission after interferon-alpha … transcriptase-polymerase chain reaction predicts outcome after …

… and lower progression rates than interferon-alpha. However, … (FISH) and qualitative
polymerase chain reaction (PCR) have … The level of BCR-ABL measured by competitive Q-PCR is …

… polymerase chain reaction (PCR) and found that patients who … continuously monitored
BCR-ABL transcript levels by RT–… -positive chronic myelogenous leukemia with interferon-alpha …

… response of CML patients treated with interferon-alpha monitored by … in chronic myelogenous
leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction. …

… reverse transcriptasepolymerase chain reaction analyses (RT-… pharmacological agents such
as interferon alpha (with or … from the initial use of competitive and limiting dilution RT-PCR …

… of individual patients to treatment or to evaluate the efficacy of a particular … in chronic
myelogenous leukemia patients on interferon-α therapy by competitive polymerase chain reaction. …

… real-time quantitative polymerase chain reaction (RQ-PCR) … , whose efficacy as second-line
therapy in patients with imatinib-… of any products discussed in this article or their competitors. …

… Patients should be monitored closely with cytogenetic and possibly other analyses such as
fluorescent in situ hybridisation (FISH) and polymerase chain reaction (… Although the efficacy …

… therapy in chronic myelogenous leukemia were initiated by our group in 1982. Since then,
several trials [8-12] have confirmed its efficacy … (ICSG-CML), patients were randomly assigned …